Skip to main content

Zydus Lifesciences inks licensing pact with Daewoong Pharmaceutical

Zydus Lifesciences inks licensing pact with Daewoong Pharmaceutical Zydus Worldwide DMCC, a wholly-owned subsidiary, and Daewoong Pharmaceutical Co Ltd have entered into an exclusive licensing agreement to co-develop and commercialise Leuprolide Acetate for depot suspension in six dosage strengths for the US market, Zydus Lifesciences said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/7JxCRBY

Comments

Popular posts from this blog

German cabinet to hold secret session on Huawei#39;s role in 5G network: Report

Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology for spying, which the company denies. from Moneycontrol Business News http://bit.ly/2TyXzFb

List of tax defaulters to be published from tomorrow: Kiran Bedi

Bedi had said the government would publish the names of defaulters in newspapers and also announce them on FM radio channels. from Moneycontrol Business News https://ift.tt/2yU0Uch

List of tax defaulters to be published from Friday: Kiran Bedi

Bedi had said the government would publish the names of defaulters in newspapers and also announce them on FM radio channels. from Moneycontrol Business News https://ift.tt/2yToJRc